[{"indications": "Indications\u00a0see under Dose", "name": "BISOPROLOL FUMARATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.4 Beta-adrenoceptor blocking drugs", "BISOPROLOL FUMARATE"], "cautions": "Cautions\u00a0see under Propranolol Hydrochloride; ensure heart failure not worsening before increasing\r\ndose", "side-effects": "Side-effects\u00a0see under Propranolol Hydrochloride; also less commonly depression, muscle weakness,\r\nand cramp; rarely hypertriglyceridaemia, syncope,\r\nand hearing impairment; very rarely conjunctivitis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2482.htm", "doses": ["Hypertension and angina, usually 10\u00a0mg once daily (5\u00a0mg\r\nmay be adequate in some patients); max. 20\u00a0mg daily", "Adjunct in heart failure (section 2.5.5), initially 1.25\u00a0mg once daily (in the morning)\r\nfor 1 week then, if well tolerated, increased to 2.5\u00a0mg once daily\r\nfor 1 week, then 3.75\u00a0mg once daily for 1 week, then 5\u00a0mg once daily\r\nfor 4 weeks, then 7.5\u00a0mg once daily for 4 weeks, then 10\u00a0mg once daily;\r\nmax. 10\u00a0mg daily"], "pregnancy": "Pregnancy\u00a0\n(From 2.4 Beta-adrenoceptor blocking drugs: British National Formulary)\nPregnancy\u00a0Beta-blockers may cause intra-uterine growth restriction, neonatal hypoglycaemia, and bradycardia; the risk is greater in severe hypertension. The use of labetalol in maternal hypertension is not known to be harmful, except possibly in the first trimester. Information on the safety of carvedilol during pregnancy is lacking. If beta-blockers are used close to delivery, infants should be monitored for signs of beta-blockade (and alpha-blockade with labetalol or carvedilol). For the treatment of hypertension in pregnancy, see section 2.5."}]